Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds
Pfs25 is a leading candidate for a malaria transmission-blocking vaccine whose potential has been demonstrated in a phase 1 trial with recombinant Pfs25 formulated with Montanide ISA51. Because of limited sequence polymorphism, the anti-Pfs25 antibodies induced by this vaccine are likely to have tra...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/31917 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.31917 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.319172018-10-19T12:24:15Z Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds Dari F. Da Saurabh Dixit Jetsumon Sattabonkot Jianbing Mu Luc Abate Bhanumati Ramineni Jean Bosco Ouedraogo Nicholas J. MacDonald Michael P. Fay Xin zhuan Su Anna Cohuet Yimin Wu Institut de Recherche en Sciences de la Santé (IRSS) Maladies Infectieuses et Vecteurs : Ecologie, Genetique, Evolution et Controle National Institute of Allergy and Infectious Diseases Armed Forces Research Institute of Medical Sciences, Thailand Mahidol University Immunology and Microbiology Medicine Pfs25 is a leading candidate for a malaria transmission-blocking vaccine whose potential has been demonstrated in a phase 1 trial with recombinant Pfs25 formulated with Montanide ISA51. Because of limited sequence polymorphism, the anti-Pfs25 antibodies induced by this vaccine are likely to have transmission-blocking or -reducing activity against most, if not all, field isolates. To test this hypothesis, we evaluated transmission-blocking activities by membrane feeding assay of anti-Pfs25 plasma from the Pfs25/ISA51 phase 1 trial against Plasmodium falciparum parasites from patients in two different geographical regions of the world, Thailand and Burkina Faso. In parallel, parasite isolates from these patients were sequenced for the Pfs25 gene and genotyped for seven microsatellites. The results indicate that despite different genetic backgrounds among parasite isolates, the Pfs25 sequences are highly conserved, with a single nonsynonymous nucleotide polymorphism detected in 1 of 41 patients in Thailand and Burkina Faso. The anti-Pfs25 immune plasma had significantly higher transmission-reducing activity against parasite isolates from the two geographical regions than the nonimmune controls (P<0.0001). © 2013, American Society for Microbiology. 2018-10-19T05:03:46Z 2018-10-19T05:03:46Z 2013-06-01 Article Infection and Immunity. Vol.81, No.6 (2013), 1984-1989 10.1128/IAI.00016-13 10985522 00199567 2-s2.0-84877799661 https://repository.li.mahidol.ac.th/handle/123456789/31917 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877799661&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Immunology and Microbiology Medicine |
spellingShingle |
Immunology and Microbiology Medicine Dari F. Da Saurabh Dixit Jetsumon Sattabonkot Jianbing Mu Luc Abate Bhanumati Ramineni Jean Bosco Ouedraogo Nicholas J. MacDonald Michael P. Fay Xin zhuan Su Anna Cohuet Yimin Wu Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds |
description |
Pfs25 is a leading candidate for a malaria transmission-blocking vaccine whose potential has been demonstrated in a phase 1 trial with recombinant Pfs25 formulated with Montanide ISA51. Because of limited sequence polymorphism, the anti-Pfs25 antibodies induced by this vaccine are likely to have transmission-blocking or -reducing activity against most, if not all, field isolates. To test this hypothesis, we evaluated transmission-blocking activities by membrane feeding assay of anti-Pfs25 plasma from the Pfs25/ISA51 phase 1 trial against Plasmodium falciparum parasites from patients in two different geographical regions of the world, Thailand and Burkina Faso. In parallel, parasite isolates from these patients were sequenced for the Pfs25 gene and genotyped for seven microsatellites. The results indicate that despite different genetic backgrounds among parasite isolates, the Pfs25 sequences are highly conserved, with a single nonsynonymous nucleotide polymorphism detected in 1 of 41 patients in Thailand and Burkina Faso. The anti-Pfs25 immune plasma had significantly higher transmission-reducing activity against parasite isolates from the two geographical regions than the nonimmune controls (P<0.0001). © 2013, American Society for Microbiology. |
author2 |
Institut de Recherche en Sciences de la Santé (IRSS) |
author_facet |
Institut de Recherche en Sciences de la Santé (IRSS) Dari F. Da Saurabh Dixit Jetsumon Sattabonkot Jianbing Mu Luc Abate Bhanumati Ramineni Jean Bosco Ouedraogo Nicholas J. MacDonald Michael P. Fay Xin zhuan Su Anna Cohuet Yimin Wu |
format |
Article |
author |
Dari F. Da Saurabh Dixit Jetsumon Sattabonkot Jianbing Mu Luc Abate Bhanumati Ramineni Jean Bosco Ouedraogo Nicholas J. MacDonald Michael P. Fay Xin zhuan Su Anna Cohuet Yimin Wu |
author_sort |
Dari F. Da |
title |
Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds |
title_short |
Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds |
title_full |
Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds |
title_fullStr |
Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds |
title_full_unstemmed |
Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds |
title_sort |
anti-pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/31917 |
_version_ |
1763493287485767680 |